Questions people ask about Stuhlprobe Männer

Men often ask whether a stool sample test (e.g., microbiome analysis) can reveal insights about digestion, inflammation, or even prostate health. The evidence is mixed: while stool markers like calprotectin are clinically validated for inflammatory bowel disease (IBD), most direct-to-consumer microbiome tests rely on mechanistic or associative evidence (GWAS, correlation studies). They cannot diagnose specific diseases or provide personalized diet plans beyond general advice. Moreover, reference ranges for men are often lacking – most data come from mixed or female cohorts. A stool test may serve as a conversation starter with a doctor, but it does not replace clinical evaluation for symptoms like blood in stool, persistent diarrhea, or unexplained weight loss. Be cautious of overblown claims: no test reliably predicts prostate cancer risk. Overall evidence level: mixed.